Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01488734 · ClinicalTrials.gov registry record · NA
Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT01488734: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01488734 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01488734, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy of two different amounts of vitamin D2 (600 or 4000 International Units/day) provided by mushrooms added to one of the daily meals versus same doses of vitamin D3 provided as oral supplements sold in any drugstore in reaching adequate or optimal blood levels of 25(OH)D in people with Vitamin D deficiency and pre-diabetes (high blood sugar without full blown diabetes) or the metabolic syndrome. Metabolic syndrome is the name of a group of risk factors that raise the risk for heart disease and other health problems, such as diabetes and stroke as described by the US department of Health and Human Services. This study will also attempt to demonstrate and compare the effect of the intervention with above two doses of vitamin D on blood levels of tests that show inflammation.
Primary Outcome
To compare the efficacy of two different doses of vitamin D2 (600 or 4000 IU/day) provided by Vitamin D2 fortified mushrooms added to one of the daily meals versus same doses of vitamin D3 provided as oral supplements in reaching adequate or optimal circulating levels of 25(OH) D in a racially diverse group of subjects with Vitamin D deficiency and pre-diabetes or the metabolic syndrome.
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Mushroom with 600 IU vitamin D2
- DIETARY_SUPPLEMENT Mushroom with 4000 IU Vitamin D2
- DIETARY_SUPPLEMENT 600 IU Vitamin D3 and untreated mushroom
- DIETARY_SUPPLEMENT 4000 IU Vitamin D3 and untreated mushroom
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01488734 record still lists
NCT01488734 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT01488734 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01488734 about?
NCT01488734 is a clinical study titled "Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom". The purpose of this study is to compare the safety and efficacy of two different amounts of vitamin D2 (600 or 4000 International Units/day) provided by mushrooms added to one of the daily meals versus same doses of vitamin D3 provided as oral supplements sold in any drugstore in reaching adequate o...
What is the current status of trial NCT01488734?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2011-11. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01488734?
The interventions under investigation include: Placebo (DRUG), Mushroom with 600 IU vitamin D2 (DIETARY_SUPPLEMENT), Mushroom with 4000 IU Vitamin D2 (DIETARY_SUPPLEMENT), 600 IU Vitamin D3 and untreated mushroom (DIETARY_SUPPLEMENT), 4000 IU Vitamin D3 and untreated mushroom (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01488734?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01488734's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia